Australian Government Department of Health, Disability and Ageing logo
MRFF BioMedTech Incubator

BioMedTech Incubator

Supports incubator organisations enabling early-stage translation and commercialisation of biomedical innovations.

OpenAustralian Government Department of Health, Disability and AgeingAustraliaDeep-tech · core fit

The 2026 BioMedTech Incubator is a grant opportunity funded through the Australian Government's Medical Research Future Fund (MRFF) Medical Research Commercialisation Initiative, which has allocated A$450 million over ten years from 2024-25 to 2033-34. The BioMedTech Incubator sub-program provides up to A$33 million per awarded incubator organisation to support early-stage translation and commercialisation of biomedical and health technology innovations, with a focus on Australian small and medium enterprises. The program is delivered externally by MTPConnect, a not-for-profit medical technology industry body, rather than directly by the Department of Health, Disability and Ageing.

Applications are open to Australian-based organisations — including for-profits, nonprofits, universities, and research organisations — that can credibly operate as incubators for biomedical or health technology SMEs. Individuals are ineligible. The predecessor sub-programs (BioMedTech Horizons and Biomedical Translation Bridge) are explicitly closed for new funding; this 2026 round continues the incubator stream with a fresh A$99 million tranche covering three years from 2024-25. Applications are submitted via GrantConnect (grants.gov.au), not through DoHDA directly. The MRFF general enquiries contact is MRFF@health.gov.au, and MTPConnect can be reached at 03 9070 8298.

Organisations best positioned to win this grant are those with established networks in the Australian biomedical and health technology ecosystem, a demonstrable track record supporting SME translation and commercialisation, and the administrative capacity to manage grants of up to A$33 million. The 2026 round sits within Australia's broader MRFF 3rd 10-year Investment Plan (A$6.5 billion, 2024-25 to 2033-34), giving awarded incubators multi-year visibility into the government's commercialisation priorities.

Funds incubator organisations to support early-stage translation and commercialisation of biomedical and health technology innovations for Australian SMEs, with up to A$33 million per incubator.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.22 Jul 2026
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see the timeline

Last verified: 30 Jun 2026Source: business.gov.au